Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: A pilot study

@article{Hetz2006MolecularAR,
  title={Molecular adsorbent recirculating system in patients with early allograft dysfunction after liver transplantation: A pilot study},
  author={Hubert Hetz and Peter Faybik and Gabriela Berlakovich and Amir Baker and Andreas Bacher and Christopher K Burghuber and Sigrid E Sandner and Heinz Steltzer and Claus Krenn},
  journal={Liver Transplantation},
  year={2006},
  volume={12}
}
Early allograft dysfunction (EAD) after orthotopic liver transplantation (OLT) causes marked morbidity and mortality. We conducted a prospective pilot study to assess the safety and efficacy of molecular adsorbent recirculating system (MARS) in treatment of EAD after OLT. Twelve consecutive adult liver allograft recipients with a median age of 48 years, 9 of whom were male, were prospectively included and supported with MARS. EAD was defined as the presence of at least 2 of the following: serum… 
Comparison of the molecular adsorbent recirculating system and plasmapheresis for patients with graft dysfunction after liver transplantation.
TLDR
Both MARS and PLP are alternative supportive treatments for graft dysfunction after OLT and significantly improved bilirubin values after the completion of treatment.
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs.
TLDR
In all patients, a decrease in serum bilirubin, bile acids, serum creatinine, and ammonia levels was observed after treatment with MARS, and a considerable improvement of HE, as well as renal and synthetic liver functions, was observed in 4 of 5 patients with graft dysfunction, but not among those with primary nonfunction.
Rescue of a marginal liver graft by sequential treatment with molecular adsorbent recirculating system and transjugular intrahepatic portosystemic shunt: a case report.
TLDR
A 53-year-old man with alcoholic liver cirrhosis underwent orthotopic liver transplantation using a marginal graft and persistent cholestasis post-OLT was successfully treated using a molecular adsorbent recirculating system (MARS and TIPS), capable of rescuing a liver graft.
Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: A national multicenter study
TLDR
It is suggested that MARS should be mainly used as a bridge to liver transplantation, and survival was correlated with being listed for most etiologies and with the intensity of treatment in ALF.
Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).
Extracorporeal liver support has been a much studied topic throughout the last 50 years. Albumin dialysis as a therapeutic option for patients with acute liver failure or acute decompensation of
Transplant Hepatectomy With Portacaval Shunt and MARS Therapy for Perioperative Catastrophe: A Series of Four Liver Transplant Cases
TLDR
Although catastrophic liver failure is highly challenging, acceptable outcomes can be achieved with timely hepatectomy with portacaval shunt and retransplantation, particularly in patients supported with the Molecular Adsorbent Recirculating System device.
Acute-on-chronic liver failure: extracorporeal liver assist devices
TLDR
Liver support systems are safe and well tolerated when used in management of patients with ACLF and should continue in controlled clinical trials to explore their role in bridging patients to liver transplantation or recovery in well defined patient groups.
Albumin Dialysis MARS: Knowledge from 10 Years of Clinical Investigation
TLDR
Together, albumin dialysis represents a valuable therapeutic tool for the treatment of various types of liver failure and ongoing and future studies will help define the optimal patient selection and technical process parameters such as session length and frequency of treatment.
Effectiveness of Plasmapheresis as a Liver Support for Graft Dysfunction Following Adult Living Donor Liver Transplantation
TLDR
It is suggested to perform active application of PP therapy for liver recipients showing severe graft dysfunction of total bilirubin greater than 15∼20 mg/dL, especially during the early posttransplant period.
A new index predicts early allograft dysfunction following living donor liver transplantation: A propensity score analysis.
  • Jiu-lin Song, Jian Yang, +10 authors Li Jiang
  • Medicine
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2017
TLDR
The postoperative AGR is a practical index for predicting early allograft dysfunction after living donor liver transplantation.
...
1
2
3
4
...

References

SHOWING 1-10 OF 39 REFERENCES
A PILOT STUDY OF INDOCYANINE GREEN CLEARANCE AS AN EARLY PREDICTOR OF GRAFT FUNCTION
TLDR
Indocyanine green clearance measured on the day after liver transplantation accurately reflects graft function and may be used to predict graft survival and final outcome, according to a threshold value of 200 ml/min reliably predicted outcome.
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial
  • S. Mitzner, J. Stange, +14 authors R. Schmidt
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2000
TLDR
It is concluded that the removal of albumin‐bound substances with the MARS method can contribute to the treatment of type I HRS.
Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study
TLDR
Although MARS leads to a further decrease in platelet count and fibrinogen concentration, platelet function, measured as the contribution of the platelets to the clot firmness in TEG, remains stable, and according to TEG-based results, MARS does not enhance fibrinolysis.
Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
TLDR
Recipients who develop EAD have longer ICU and hospital stays and greater mortality than those without and a logistic regression model combining donor, graft, and recipient factors predicted EAD better than models examining these factors in isolation.
Significance of early aminotransferase elevation after liver transplantation.
TLDR
It is concluded that patient survival is influenced by IPRI only when it is extreme (ASTmax>5000 U/L), provided parameters of graft function are used in conjunction with aminotransferase values to assess the need for prompt retransplantation.
Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantation
TLDR
The hypothesis that primary graft function is of major importance for the long‐term survival of liver transplants is confirmed, which leads to the interpretation that patients with a poor primary function have the worst survival prognosis, and may be candidates for early retransplantation.
Clinical Implications of Hepatic Preservation Injury After Adult Liver Transplantation
  • M. Glanemann, J. Langrehr, +4 authors P. Neuhaus
  • Medicine
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2003
TLDR
Graft survival was significantly lower in patients with severe preservation injury, when compared to minor or moderate injury, and patient survival remained comparable between all groups.
Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study
TLDR
ECAD appears to be effective and safe for the short‐term treatment of patients with cirrhosis and superimposed acute injury associated with progressive hyperbilirubinemia and may be useful for increasing survival in such patients awaiting liver transplantation.
Indocyanine green elimination test in orthotopic liver recipients
TLDR
Multivariate analysis using the Cox proportional hazard model revealed that KICG on postoperative day 1 was a better predictor of liver‐ related graft outcome than any of the conventional liver function tests.
Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial
  • L. Schmidt, L. P. Wang, B. Hansen, F. Larsen
  • Medicine
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
  • 2003
TLDR
Systemic hemodynamic values tend to normalize, whereas systemic VO2 decreases during MARS treatment in patients with HALF, and these effects cannot be explained by the degree of cooling associated with MARS.
...
1
2
3
4
...